Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Kim

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Cancers|December 10, 2021
Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular CarcinomaMoon Haeng Hur, Jeong-Hoon Lee, Ju Yeon Kim, et al.
JAMA Network Open|August 9, 2021
Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal FluidMichael D White, Robert H Klein, Brian Shaw, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2020
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial PeritonitisSun Woong Kim, Jun Sik Yoon, Junyong Park, et al.
Journal of Hepatology|December 22, 2024
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis BHyunjae Shin, Moon Haeng Hur, Byeong Geun Song, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Gut|March 27, 2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyMinseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Cancers|December 10, 2021
Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular CarcinomaMoon Haeng Hur, Jeong-Hoon Lee, Ju Yeon Kim, et al.
JAMA Network Open|August 9, 2021
Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal FluidMichael D White, Robert H Klein, Brian Shaw, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2020
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial PeritonitisSun Woong Kim, Jun Sik Yoon, Junyong Park, et al.
Journal of Hepatology|December 22, 2024
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis BHyunjae Shin, Moon Haeng Hur, Byeong Geun Song, et al.
Nature Medicine|June 20, 2020
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Nature Medicine|June 3, 2020
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosisPriscilla K Brastianos, Eudocia Quant Lee, Justine V Cohen, et al.
Gut|March 27, 2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyMinseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, et al.
Pageof 11